A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan Database
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Rheumatology
Reference22 articles.
1. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
3. Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
4. Febuxostat: A Selective Xanthine Oxidase Inhibitor for the Treatment of Hyperuricemia and Gout
5. Febuxostat: a new treatment for hyperuricaemia in gout
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current state and prospects of gout treatment in Korea;The Korean Journal of Internal Medicine;2022-07-01
2. Factors associated with achieving target serum uric acid level and occurrence of gouty arthritis: A retrospective observational study of Japanese health insurance claims data;Pharmacoepidemiology and Drug Safety;2020-09-16
3. Investigating the Potential of Transmucosal Delivery of Febuxostat from Oral Lyophilized Tablets Loaded with a Self-Nanoemulsifying Delivery System;Pharmaceutics;2020-06-10
4. Comparison of long-term efficacy and renal safety of febuxostat and allopurinol in patients with chronic kidney diseases;Int. Journal of Clinical Pharmacology and Therapeutics;2020-01-01
5. Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial;Clinical Rheumatology;2019-08-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3